Zepp Health Corporation
NYSE:ZEPPConsumer Electronics
Technology
$3.55 -0.58%
-$0.03 today
- Market cap
- $50.84M
- Beta
- 1.78
- P/E (TTM)
- -0.1
- EPS (TTM)
- -$282.07
52W Low $2.36High $61.85
Volume 0.04M
Average 0.13M
Income Statement
Follow revenue through to earnings.
Revenue
$1.82B
FY 2025 · Annual
+36.1% YoYOperating Income
-$204.93M
FY 2025 · Annual
Net Income
-$280.92M
FY 2025 · Annual
Income Statement
CNY
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.17B | 4.22B | 2.5B | 1.33B | 1.82B |
| Cost of Revenue | 4.88B | 3.4B | 1.84B | 820.57M | 1.1B |
| Gross Profit | 1.29B | 817.22M | 653.7M | 512.88M | 711.63M |
| Gross Margin | 20.9% | 19.4% | 26.2% | 38.5% | 39.2% |
| Research & Development | 508.41M | 526.2M | 364.53M | 337.07M | 317.73M |
| Selling, General & Admin | 687.6M | 708.46M | 504.69M | 520.85M | 582.64M |
| Operating Expenses | 1.2B | 1.23B | 869.22M | 857.92M | 916.56M |
| Depreciation & Amortization | 51.21M | 59.65M | 54.43M | 36.64M | 31.71M |
| EBITDA | 200.8M | (261.43M) | (142.88M) | (345.66M) | (191.48M) |
| EBITDA Margin | 3.3% | -6.2% | -5.7% | -25.9% | -10.5% |
| Operating Income | 92.73M | (417.45M) | (215.52M) | (345.04M) | (204.93M) |
| Operating Margin | 1.5% | -9.9% | -8.6% | -25.9% | -11.3% |
| Interest Income | 16.47M | 12.55M | 21.86M | 26.81M | 10.7M |
| Interest Expense | 44.3M | 58M | 47.79M | 40.54M | 39.94M |
| Other Income / Expenses | 53.06M | 56.34M | (21.7M) | (108.55M) | (58.2M) |
| Income Before Tax | 145.78M | (361.11M) | (237.22M) | (453.59M) | (263.13M) |
| Pre-Tax Margin | 2.4% | -8.6% | -9.5% | -34.0% | -14.5% |
| Income Tax Expense | 10.61M | (67.03M) | (17.2M) | 99.99M | 17.79M |
| Net Income | 136.02M | (293.37M) | (220.49M) | (554.13M) | (280.92M) |
| Net Margin | 2.2% | -7.0% | -8.8% | -41.6% | -15.5% |
| EPS (Basic) | 1.38 | (2.71) | (1.96) | (34.16) | (283.04) |
| EPS (Diluted) | 1.31 | (2.71) | (1.96) | (34.16) | (283.04) |
| 15.76M | 15.39M | 15.2M | 16.18M | 993.87K | |
| 16.52M | 15.39M | 15.2M | 16.18M | 993.87K |
ZEPP Earnings Waterfall · TTM
NYSE:ZEPP · Revenue to Net Income
Key Ratios
EPS$-217.81
Gross Margin38.5%
Net Margin-16.5%
P/E Ratio-28.6
P/S Ratio2.7
Analysis
$1.9B of revenue converted into -$279.8M of net income for the selected period. Gross margin is 38.5% and net margin is -16.5%, showing how much revenue survives after costs and taxes. EPS is $-217.81, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Sep 25, 2026 | |
| 6-K | 6-K filing | Sep 2, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 13, 2026 |
How much revenue does ZEPP generate?
Zepp Health Corporation (ZEPP) reported $1.82B of revenue in fiscal 2025.
Is ZEPP profitable?
Zepp Health Corporation (ZEPP) reported -$280.92M of net income, with a net margin of -15.5%.
Continue the stock analysis
Jump to another research area for this company.